AGP Executive Report
Last update: 8 hours agoHIV Prevention Boost in Douala: Cameroon has started a pilot rollout of CAB-PrEP, a long-acting injectable HIV prevention drug (cabotegravir) given every two months, with officials saying it’s up to 95% effective and meant to add to condoms, testing, and follow-up care; the pilot begins in high-transmission areas, starting with Douala, and stresses public information, medical supervision, and community action to reduce stigma. HIV Progress Update: New national data shows Cameroon has met two of the UN “95-95-95” targets: 96.4% of people diagnosed with HIV are on antiretroviral treatment and 95% of those on treatment have viral suppression, while the “know your status” target remains the main gap. Cholera Alert Beyond Cameroon: In Nigeria’s jihadist-hit northeast, insecurity and weak health infrastructure are hampering a cholera outbreak, with AFP reporting dozens of deaths and high daily patient numbers in Lake Chad communities. Public Health Rights Move: The UN Human Rights Council has adopted a resolution recognizing neglected tropical diseases as a human rights issue, highlighting the need for more than medicines—especially for people facing isolation and limited care. Water Access Push (SEWASH): Cameroon is moving ahead with the SEWASH Project to expand safe water and sanitation in water-stressed regions, backed by World Bank financing, aiming to improve public health and service access. Community Health & Safety: Cameroon’s Jehovah’s Witnesses in Yaoundé are facing government engagement over civic duties and guidance related to vaccination and blood donation policies.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.